Alkem Laboratories Limited
ALKEM
Pozycja w akcjach
#2815
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Cena akcji
$55.19
Kapitalizacja rynkowa
$6.60B
Zmiana (1 dzień)
-0.06%
Zmiana (1 rok)
-12.43%
Kraj
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategoria
Healthcare
Zyski dla Alkem Laboratories Limited (ALKEM)
Zyski w Jun 2026 TTM: $316.88M
Według najnowszych raportów finansowych Alkem Laboratories Limited, obecny zysk firmy wynosi $316.88M. W roku 2024 firma osiągnęła zysk w wysokości $242.63M, wzrost w porównaniu do zysku z roku 2023, który wynosił $158.77M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Alkem Laboratories Limited od 2010 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $316.88M | 7.25% |
| 2025 | $295.47M | 21.78% |
| 2024 | $242.63M | 52.82% |
| 2023 | $158.77M | -34.65% |
| 2022 | $242.96M | -3.45% |
| 2021 | $251.64M | 50.48% |
| 2020 | $167.23M | 21.64% |
| 2019 | $137.48M | -3.33% |
| 2018 | $142.22M | -4.39% |
| 2017 | $148.75M | 6.15% |
| 2016 | $140.14M | 93.97% |
| 2015 | $72.25M | -3.44% |
| 2014 | $74.83M | -20.27% |
| 2013 | $93.85M | 4.73% |
| 2012 | $89.61M | 12.42% |
| 2011 | $79.71M | 46.07% |
| 2010 | $54.57M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 456.85% |
IN
|
